Welcome to the February 2026 issue of Regulatory Rapporteur  which focuses on MedTech.

As medical devices become increasingly complex, collaborative and deeply rooted in day-to-day life, regulation is no longer a background consideration; it is a determining factor.

This February issue is shaped by a unifying theme: how risk, evidence, inclusivity and innovation are being brought to the forefront by evolving regulatory expectations across the medical device lifecycle. The articles challenge a common belief: that regulation is something to be ‘managed’, and instead, they invite readers to consider regulation as a lens through which better, safer and more equitable devices can be created.